-
-
-
Ki-Suck Jung
President, APSR 2022
Local Congress Committee
Professor, Hallym University College of Medicine -
Jae Jeong Shim
Secretary General, APSR 2022
Local Congress Committee
Professor, Korea University College of Medicine -
Jang-Won Sohn
Vice Secretary General, APSR 2022
Local Congress Committee
Professor, Hanyang University College of Medicine -
Kwang Ha Yoo
Vice Secretary General, APSR 2022
Local Congress Committee
Professor, Konkuk University School of Medicine -
Chin Kook Rhee
Vice Secretary General, APSR 2022
Local Congress Committee
Professor, The Catholic University of Korea College of Medicine
-
Speaker's Highlight
-
-
Don Sin
University of British Columbia, St. Paul Hospital (Canada)
Kenneth R. Chapman
Toronto General Hospital Research Institute (Canada)
-
Parameswaran Nair
McMaster University (Canada)
Carolyn Calfee
UCSF (U.S.A.)
-
Gregory P. Downey
University of Colorado School of Medicine (U.S.A.)
David A. Schwartz
University of Colorado School of Medicine (U.S.A.)
-
Neil Schluger
Tuberculosis Control Branch, California Department of Public Health (U.S.A.)
Nick Kim
Critical Care & Sleep Medicine, University of California San Diego (U.S.A.)
-
Nicola Hananiah
Baylor College of Medicine (U.S.A.)
Jae-Joon Yim
Seoul National University College of Medicine (Republic of Korea)
-
Koichiro Asano
Tokai University School of Medicine (Japan)
Diahn-Warng Perng
Taipei Veterans General Hospital (Taiwan)
-
Konstantinos Kostikas
University of Ioannina (Greece)
Karin Klooster
University Medical Center Groningen (Kingdom of the Netherlands)
-
Managing hemoptysis in bronchiectasis: embolisation and surgery
Bleeding from diseased bronchi is a common but potentially fatal complication of bronchiectasis. Blood-streaked sputum may reflect airway inflammation, infection or vascular fragility; larger or rapidly accumulating bleeding can flood the airway before circulatory collapse. Severity depends on bleeding speed, respiratory and haemodynamic compromise, lung reserve and anticoagulant use, rather than relying on an estimate of volume.
Management has three linked aims: protect the airway, identify and stop the bleeding source, and reduce recurrence. Bronchial artery embolisation is often preferred for significant or recurrent haemoptysis when the vessel can be targeted. Lung resection can be appropriate for selected patients with localised disease, failed embolisation or another surgical indication. These decisions benefit from input from respiratory medicine, interventional radiology, thoracic surgery, anaesthesia and intensive care.
Recognising an emergency
Red flags include large-volume or repeated bleeding, breathlessness, cyanosis, chest pain, tachycardia, falling blood pressure, confusion or inability to clear blood. A first episode, fever, weight loss or markedly reduced exercise tolerance also warrants prompt investigation, even if the initial bleed seems minor.
Reported volume is unreliable, and no numerical threshold should delay care for a deteriorating patient. Even a modest amount can be fatal when the airway is compromised by extensive disease, poor cough strength or blood clots. Bronchiectasis may also be associated with pulmonary hypertension or cor pulmonale, reducing the margin for physiological instability.
Recurrent bleeding often comes from hypertrophied bronchial arteries and systemic-to-pulmonary collaterals. Infection can intensify inflammation and vessel fragility, so control of the source must be paired with treatment of pulmonary infection and other contributors.
Assessment and initial stabilisation
Airway, breathing and circulation take priority. Resuscitation includes supplemental oxygen, suction, intravenous access, vital-sign monitoring and blood tests for full blood count, coagulation, renal function and cross-matching. A chest radiograph helps identify the bleeding side, widespread disease or another cause, but chest examination and imaging do not reliably exclude a dangerous source.
If the patient is stable, CT angiography of the chest is usually the key investigation because it maps bronchial and non-bronchial arterial anatomy before catheter angiography. CT does not replace urgent resuscitation, and contrast decisions should account for renal impairment and allergy history. Bronchoscopy may be undertaken during the same admission if localisation or immediate airway control is needed.
Anticoagulants and antiplatelet medicines must be reviewed urgently. Life-threatening bleeding may require reversal under local haematology or emergency protocols, balanced against thrombosis risk; patients should not stop anticoagulants independently. In Australia, emergency departments and specialist teams can coordinate these decisions, while a general-practitioner referral supports outpatient investigation when the patient is stable.
The role of bronchoscopy
Flexible bronchoscopy can confirm that blood is coming from the lower airway, exclude a tracheobronchial lesion and identify the bleeding segment. It may be especially useful with recurrent bleeding, previous thoracic surgery or embolisation, uncertain anatomy, or continued deterioration despite initial measures.
Bronchoscopy can also control selected bleeding through cold-saline lavage, dilute adrenaline, balloon tamponade or targeted coagulation. These measures require close anaesthetic and respiratory support. They are generally used as a bridge, or for bleeding that can be managed endoscopically, rather than as the sole strategy for substantial haemoptysis.
When bronchoscopy cannot localise diffuse bleeding, or the patient is too unstable for prolonged instrumentation, angiographic embolisation may provide faster source control. The respiratory and interventional teams should decide the sequence according to stability rather than following a fixed pathway.
Bronchial artery embolisation
After urgent stabilisation, catheter angiography can identify the responsible bronchial artery and dangerous collateral vessels. The interventional radiologist may use coils, particles, gelatin or liquid embolic agents, often in combination, while preserving spinal and other critical arterial supply. Treatment is usually selective, and the anatomy may differ markedly from that shown on CT.
Embolisation commonly stops bleeding quickly and is especially valuable for recurrent haemoptysis without a single surgically removable focus. It is less suitable when the bleeding cannot be reached, when vascular supply is inaccessible, or when contrast and catheter techniques carry unacceptable risk. It may also serve as a bridge to surgery in life-threatening disease.
Important complications include contrast-related kidney injury, arterial dissection, stroke, spinal cord ischaemia, skin necrosis and rebleeding from new or enlarged collaterals. Patients need observation, pain control, neurological and renal checks, and a clear plan for recurrent bleeding. Planning follow-up with the respiratory team is as important as the procedure itself.
When lung surgery is appropriate
Lobectomy or, in selected cases, segmentectomy may be offered when bleeding is confined to a removable region, the patient has adequate cardiopulmonary reserve, and embolisation has failed, is contraindicated or is unlikely to provide durable control. A suspected cancer, cavitary lesion or competing surgical indication may strengthen the case for resection.
Surgical decisions require review of recent and previous bleeding, bronchoscopy and angiographic findings, pulmonary function, oxygenation, exercise capacity and the distribution of bronchiectasis. Resection can remove the source definitively, but operative bleeding, bronchial stump complications, infection, prolonged air leak and respiratory failure are more likely in emergency surgery and patients with limited reserve.
Diffuse bilateral disease, poor lung function or severe comorbidity generally favours a non-operative strategy, usually embolisation with rehabilitation and infection control. A patient with acceptable imaging but inadequate physiological reserve may face more harm from surgery than from carefully targeted embolisation.
Recovery, prevention and Australian follow-up
After the acute episode, care includes airway clearance, appropriate infection treatment, vaccination review, anaemia assessment, optimisation of cardiovascular disease and structured pulmonary rehabilitation. Long-term macrolide therapy may reduce exacerbations in selected people with frequent infections, but requires specialist review because of drug interactions, QT prolongation, hearing effects and antimicrobial resistance.
Australian treatment is commonly delivered through public hospitals, with Medicare support for eligible specialist services. A general-practitioner referral is useful for outpatient review, while emergency bleeding is assessed directly in an emergency department. Major public tertiary centres in Sydney, Melbourne, Brisbane, Perth and Adelaide provide the full combination of respiratory medicine, CT angiography, interventional radiology and thoracic surgery; regional and remote patients may require aeromedical transfer through the Royal Flying Doctor Service or state retrieval services.
Distance, weather, limited transport and the need to travel away from family can disrupt follow-up, and the disproportionate burden of bronchiectasis in Aboriginal and Torres Strait Islander communities makes accessible local services particularly important. Medicare usually covers public inpatient care, yet outpatient specialist fees, out-of-pocket private hospital treatment and accommodation can still create costs, so social work and travel support should be arranged early. For an active, uncontrolled bleed, the next step is emergency transfer via 000 to a hospital with respiratory, interventional radiology and thoracic surgery support.
Richard Russell
Nuffield Department of Clinical Medicine, University of Oxford (United Kingdom)
-
Mona Bafadhel
King’s College London (United Kingdom)
David Jackson
Guy’s and St Thomas’ Hospital, King’s College London (United Kingdom)
-
James Chalmers
University of Dundee (United Kingdom)
David Price
University of Aberdeen (United Kingdom)
-